Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma

Published:2019-02-07 Issue:4 Volume:39 Page:714-726
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Schulte Lena¹,Scheiner Bernhard²^ORCID,Voigtländer Torsten¹,Koch Sandra³,Schweitzer Nora¹^ORCID,Marhenke Silke¹,Ivanyi Philipp⁴,Manns Michael P.¹,Rodt Thomas⁵,Hinrichs Jan B.⁵,Weinmann Arndt³,Pinter Matthias²^ORCID,Vogel Arndt¹,Kirstein Martha M.¹^ORCID

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School Hannover Germany

2. Division of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

3. Department of Internal Medicine University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany

4. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Germany

5. Hannover Medical School, Institute for Diagnostic and Interventional Radiology Hannover Germany

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14048

Reference45 articles.

1. Hepatocellular carcinoma epidemiology

2. Hepatocellular Carcinoma

3. Global cancer statistics

4. Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

5. Cellular and molecular mechanisms of metformin: an overview

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion;Cellular Oncology;2024-07-11

2. Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors;Journal of the National Comprehensive Cancer Network;2024-06

3. Biguanide-PROTACs: Modulating Mitochondrial Proteins in Pancreatic Cancer Cells;2024-03-19

4. Diabetes and Non‐alcoholic Fatty Liver Disease;Textbook of Diabetes;2024-01-12

5. The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-01